paraquat has been researched along with 2-naphthol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akishita, M; Eto, M; Iijima, K; Kano, MR; Ogawa, S; Ota, H; Ouchi, Y | 1 |
1 other study(ies) available for paraquat and 2-naphthol
Article | Year |
---|---|
Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells.
Topics: Acetylation; Animals; Benzamides; Cell Shape; Cells, Cultured; Cellular Senescence; Cilostazol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Mice; Mice, Inbred BALB C; Naphthols; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidants; Oxidative Stress; Paraquat; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Phosphorylation; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Sirtuin 1; Sirtuins; Tetrazoles; Time Factors; Tumor Suppressor Protein p53; Up-Regulation | 2008 |